Pfizer, BioNTech and Covid-19
Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...
AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...
The newest update to the COVID-19 vaccine reached pharmacies as infections in Indiana began to rise. Members of our audience ...
CSL and Arcturus Therapeutics report that their sa-mRNA COVID-19 vaccine, ARCT-154, delivered superior immunogenicity ...
Pfizer and BioNTech have started a mid-stage trial of a new version of the COVID-19 vaccine based on a version of the spike protein that they hope will offer greater and broader protection against ...
Pfizer-BioNTech's updated vaccine to protect against a recently circulating COVID-19 variant is authorized, Health Canada said on Tuesday. The federal vaccine and treatment portal lists ...
CDC Recommends Updated 2024-2025 COVID-19 and Flu Vaccines for Fall & Winter Virus Season. The CDC recommends the updated 2024-2025 COVID-19 vaccines and the updated 2024-2025 flu vaccines to protect ...
The Pfizer/BioNTech bivalent COVID-19 vaccine (Original and Omicron BA.4/BA.5) has the FDA’s EUA for use in individuals 5 years and over as a single booster dose administered at least two months ...
CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the ...